ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,888.20
      -0.01%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Journey Medical Corporation (DERM)

      7. Journey Medical Corporation (DERM) News

      DERM

      Journey Medical (DERM)

      Journey Medical Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DERM
      DateTimeSourceHeadlineSymbolCompany
      05/01/20244:01PMGlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:DERMJourney Medical Corporation
      04/25/20248:30AMGlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:DERMJourney Medical Corporation
      03/21/20244:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
      03/18/20248:30AMGlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:DERMJourney Medical Corporation
      03/15/20248:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:DERMJourney Medical Corporation
      03/13/20248:30AMGlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:DERMJourney Medical Corporation
      03/11/20248:30AMGlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:DERMJourney Medical Corporation
      02/23/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
      01/05/20248:30AMGlobeNewswire Inc.Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
      01/02/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      01/02/20244:05PMGlobeNewswire Inc.Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 MillionNASDAQ:DERMJourney Medical Corporation
      12/15/20234:46PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DERMJourney Medical Corporation
      12/08/20235:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      12/06/20238:00AMGlobeNewswire Inc.Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
      11/07/20234:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      11/07/20234:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
      10/31/20238:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:DERMJourney Medical Corporation
      10/20/20238:30AMGlobeNewswire Inc.Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)NASDAQ:DERMJourney Medical Corporation
      10/17/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
      09/26/20239:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      09/19/20234:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      09/08/20231:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
      09/06/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      09/06/20238:00AMGlobeNewswire Inc.Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian NationsNASDAQ:DERMJourney Medical Corporation
      08/18/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      08/14/20234:01PMGlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
      08/10/20234:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DERMJourney Medical Corporation
      08/08/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
      08/08/20234:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
      08/02/20234:01PMGlobeNewswire Inc.Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023NASDAQ:DERMJourney Medical Corporation
       Showing the most relevant articles for your search:NASDAQ:DERM